Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 842 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22094102A>G |
| Variant | c.849+3A>G |
| Variant Start Position | 849 |
| Location | Intron 7 |
| Amino Acid Change | p.? |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Uncertain Significance | Effect Type | Intronic |
| Variant Type | Splicing |
| PMID | 33295632, 34806794 |
| Article Count | 2 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | bp2 |
| ACMG Explanations | - |
| Variant in Clinvar | Yes |
| ClinVar Classification | Benign |
| Categories In Literature | bp2 |
| No Contrary Evidence Found | TRUE |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | FALSE |
| Literature Alleles | X-22112220-A-G |
| GnomAD Alleles | X-22112220-A-G |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |